Our Certifications
Quality and compliance credentials supporting VitaMFG manufacturing.
A Creatine-Led Healthy Aging Formula for Women
CR02 is an internal R&D concept for brands developing healthy-aging nutrition for perimenopausal and postmenopausal women. The current baseline provides 4,000 mg creatine monohydrate, 125 mcg (5,000 IU) vitamin D3 and 100 mcg vitamin K2 as MK-7 in four approximately 5 g tropical mango-passionfruit gummies.
Creatine gives the formula its primary dosage story. D3 and K2 add a separate micronutrient layer that requires tighter safety, label and medication-interaction review. The 5,000 IU D3 target is not positioned as a universal daily dose; commercial use depends on the destination market, intended user, total vitamin D intake and qualified review. Technical development focuses on high-powder gummy formation, even distribution of the oil-based vitamins, K2 stability, tropical flavor masking and finished-product verification. Final claims and specifications follow the approved formula and test results.
Why Choose VitaMFG for Women's Creatine D3 K2 Gummies?
- Clear 4 g creatine monohydrate target in one daily serving
- Perimenopause and postmenopause healthy-aging development direction
- Controlled handling of higher-load vitamin D3 oil preparation
- K2 MK-7 identity, potency and stability review
- Tropical flavor masking across a high-powder four-gummy serving
- Finished-product testing, label review and private label scale-up support
Women's Healthy Aging Gummy Product Directions
Use the complete CR02 concept as the starting point, or adapt the vitamin levels and product story after formula, safety, regulatory and sensory review.
Women's Healthy Aging Creatine D3 K2 Gummies
The complete four-gummy concept with 4 g creatine monohydrate, high-D3 development target, 100 mcg K2 MK-7 and tropical flavor.
Women's Creatine + Vitamin D3 Gummies
A simplified creatine-led direction with a project-specific vitamin D3 level selected for the intended market and user group.
Women's Creatine + K2 MK-7 Gummies
A focused route combining a transparent creatine serving with declared K2 MK-7, subject to medication-interaction and claim review.
Tropical Healthy Aging Gummies
A flavor-led direction developed to manage creatine powderiness and oil-phase notes across the complete four-gummy serving.
Perimenopause and Postmenopause Nutrition Gummies
A responsible daily-nutrition concept designed to sit beside balanced diet, strength activity and individualized professional guidance. Alongside this creatine-led healthy-aging route, menopause support capsules provide a distinct botanical-and-nutrient format for menopause-specific product positioning.
Private Label Women's Creatine Gummies
An OEM/ODM route covering formula review, D3 level, flavor, packaging, warnings, testing scope and commercial scale-up.
Product Advantages for Women's Healthy Aging Creatine D3 K2 Gummies
CR02 gives brands a creatine-first formula with two clearly declared fat-soluble vitamins and a visible four-gummy serving.
4 g Creatine Monohydrate
One four-gummy serving targets 4,000 mg of creatine monohydrate without hiding the primary amount inside a proprietary blend.
High-D3 Development Version
The current target is 125 mcg / 5,000 IU D3 per serving and requires market-specific safety and label review.
100 mcg K2 MK-7
The declared K2 amount creates a clear formula story while making raw-material identity and medication warnings commercially important.
Tropical Four-Gummy Format
A mango-passionfruit profile is developed around the taste, chew and repeat-use demands of an approximately 20 g serving.
Control Powder Load and Oil-Phase Vitamins
CR02 combines gram-level creatine with much smaller quantities of oil-based D3 and K2 preparations. Main-batch mixing alone cannot be assumed to distribute both levels consistently. VitaMFG reviews vitamin potency, carrier allocation, premixing, addition sequence, temperature exposure, mixing and depositing conditions. Defined in-process samples and formula-specific finished-product testing can then connect the declared values to the actual ingredients and process used for the evaluated batch.
Protect the High-D3 and K2 Boundaries
The image locks D3 at 125 mcg / 5,000 IU, which exceeds the U.S. adult tolerable upper intake level of 100 mcg / 4,000 IU. It cannot be presented as a routine dose for every woman. Vitamin K can also interact seriously with warfarin and similar anticoagulants. Before commercial release, the brand must review the intended population, total intake, warnings, medications, destination-market rules and qualified professional guidance. CR02 remains a development platform until those decisions are closed.
Resource Center
Certifications Download
View available factory, quality-system and certification documents.
DownloadBuilt for High-Load, Fat-Soluble Vitamin Gummy Projects
VitaMFG operates an NSF GMP-certified gummy facility under NSF/ANSI 455-2 and has more than five years of functional gummy manufacturing experience. Under standard conditions, commercial capacity can reach 8–10 metric tons per day, subject to formula, gummy weight and scheduling.
R&D, pilot review, commercial production, batch records and retained samples are coordinated within one manufacturing system. For CR02, that gives product, quality, regulatory and purchasing teams one visible path from the 600 g first trial through powder-load review, vitamin dispersion, K2 stability observation, packaging and repeat production. The high-D3 level, dietary claims, warning language, final gummy base and commercial count remain open until their supporting evidence and records are approved.
Women's Healthy Aging Gummy Projects for Different Markets
The same creatine-led platform can support several market routes while keeping the high-D3 version and K2 warnings under control.
Women's Healthy Aging Brands
Build a creatine-first product for women who prioritize strength, mobility and an active lifestyle as they age. D3 and K2 can add a micronutrient layer. A D3 K2 calcium gummy provides a calcium-led bone-nutrition route when creatine is not part of the intended formulation. But the product page should state actual amounts and avoid treating the three ingredients as proof of a guaranteed muscle, bone or longevity outcome.
Perimenopause and Postmenopause Nutrition Lines
Add a differentiated gummy to a women's midlife portfolio while acknowledging that needs vary by diet, health status, medications and laboratory results. The 5,000 IU D3 version requires a deliberate target-user and safety decision; a lower-D3 variant can be evaluated when a broader daily-use position is needed.
Active Aging and Strength Communities
Create a portable alternative to creatine powder for women who already include appropriate physical activity in their routine. The four-gummy serving and approximately 20 g total weight must be visible before purchase. Product education should keep supplementation separate from the role of resistance training, protein and overall diet.
Retail and DTC Private Label Projects
Start from channel rules, target consumer, bottle count, warning requirements and price architecture. VitaMFG can align formula data, Supplement Facts, testing and stability plans with the selected D3 level. This helps the retail page explain the product accurately without turning a high-dose development version into an unrestricted daily recommendation.
What Consumers Expect from Creatine D3 K2 Gummies
Public category reviews highlight three practical purchase factors for this combined concept: creatine gummies must avoid grit, multiple gummies must remain pleasant across the full serving, and D3 K2 gummies must stay separate inside the bottle. These are third-party category reviews, not reviews of CR02 or a VitaMFG product and not evidence of a health outcome.
Women's Healthy Aging Creatine D3 K2 Gummies Specifications
| Parameter | Development Baseline | Customization / Notes |
|---|---|---|
| Product Type | Women's Healthy Aging Creatine D3 K2 Gummies | Private Label / OEM / ODM |
| Target Direction | Perimenopause and postmenopause healthy-aging nutrition | Not a disease treatment or guaranteed muscle, bone or longevity outcome |
| Formula Version | CR02, four-gummy 600 g R&D formula V1 | Laboratory test formula; not a production formula |
| Serving Size | 4 gummies | One complete serving |
| Weight Per Gummy | Approx. 5 g | Approx. 20 g per serving; final dry weight follows trial review |
| Creatine Monohydrate | Target: 4,000 mg per serving / 1,000 mg per gummy | Final value follows approved formula and finished-product testing |
| Vitamin D3 | Target: 125 mcg / 5,000 IU per serving | High-D3 version; exceeds the U.S. adult UL and requires qualified, market-specific review |
| Vitamin K2 | Target: 100 mcg MK-7 per serving | K2 identity, all-trans specification, potency and medication warnings confirmed per project |
| Flavor | Tropical mango-passionfruit | Additional profiles available after full-serving sensory review |
| Gummy Base | Current CR02 R&D gel system | Pectin, gelatin-free, vegan and sugar-related claims require formula confirmation |
| Appearance | Confirmed after trial review | Oil preparations and tropical flavor system may influence final color and surface |
| R&D Batch Reference | 600 g wet material / approx. 120 trial gummies / 30 trial servings | Internal trial reference only; not a commercial pack count |
| Packaging | Confirmed by project | Light, heat, moisture, bottle count and retail-format requirements reviewed together |
| Testing | Creatine / D3 / K2 where analytically applicable / Microbiology / Heavy metals / Physical indicators | Final scope follows formula, label risk and destination market |
| Stability Focus | K2 retention / D3 retention / Appearance / Texture / Moisture / Sticking | Time points and storage conditions confirmed per project |
| Project Status | CR02 first-trial R&D formula | Formula → Trial → Verification → Scale-up |
| OEM/ODM | Supported | Formula, flavor, packaging and label support |
Frequently Asked Questions
Start Your Supplement Manufacturing Project
Tell us what you want to manufacture — including dosage form, formulation requirements, packaging, target market, and expected volume. We'll review your project and recommend the next steps.
Share your project details — our team will review feasibility, process alignment, and next steps.
